Rapid Therapeutic Enters Letter of Intent to Expand Production Capability to 3,000,000 MDI and $100,000,000 in Revenue Annually
30 sept. 2020 06h00 HE
|
Rapid Therapeutic Science Laboratories
DALLAS, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
Rapid Therapeutic Announces Completion of New ISO 13485 Laboratory
18 août 2020 07h00 HE
|
Rapid Therapeutic Science Laboratories
DALLAS, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
Rapid Therapeutic Science Laboratories (RTSL), Inc. engages Ezzey Digital Marketing Agency to Launch its New Lifestyle Brand “nhāler”
06 août 2020 07h00 HE
|
Rapid Therapeutic Science Laboratories
DALLAS, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
Rapid Therapeutic Science Files with FDA to Register Facility and Products
04 août 2020 07h00 HE
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
Rapid Therapeutic Completes Delivery of Additional 6,000 Units of its Proprietary Metered Dose Inhalers
14 juil. 2020 07h30 HE
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 14, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
Rapid Therapeutic Announces Major Contract is Increased by 150% to 250,000 Metered Dose Inhalers
09 juil. 2020 07h30 HE
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 09, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), a fully-reporting, early stage, emerging biotech company focused on aerosol delivery of...
Rapid Therapeutic Completes Initial Delivery of 2,000 Units of its Proprietary Metered Dose Inhalers
08 juil. 2020 07h30 HE
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 08, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing aerosol...
Rapid Therapeutic Enters Contract for Certified Lab for Manufacturing Consistent with FDA Rules
30 juin 2020 07h30 HE
|
Rapid Therapeutic Science Laboratories
DALLAS, June 30, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing aerosol...
Rapid Therapeutic Announces Record Order for 100,000 Units of its Metered Dose Inhalers Addressing $9.3 Billion CBD Market
23 juin 2020 08h30 HE
|
Rapid Therapeutic Science Laboratories
DALLAS, June 23, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), a fully-reporting, early stage, emerging biotech company focused on manufacturing and marketing...
Rapid Therapeutic Science Laboratories, Inc. Highlighted in Research Report Released by Emerald Equity Research, LLC
22 juin 2020 08h30 HE
|
Rapid Therapeutic Science Laboratories
DALLAS, June 22, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing CBD aerosol...